Children who were treated with the previous nicardipine hydrochloride 2 mg/mL oral formulation in our center from 1 January 2020 to 31 December 2020 were identified using an internal compounding software program. Electronic medical files (CDP2® software, C.PAGE patient files) and prescriptions were consulted to collect demographic data and the prescribed doses of nicardipine. The study obtained ethics approval provided by the institutional ethics committee (CERDE-HLJ: Comité d’Ethique pour la Recherche sur Données Existantes et/ou Hors Loi Jardé) with the number E2023-02.
Free full text: Click here